Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Oluwaseyi J. Balogun"'
Autor:
Rita O. Oladele, Akaninyene A. Otu, Oluwaseyi J. Balogun, Oladayo M. Babalola, Augustina O. Nwosu, Iriagbonse Iyabo Osaigbovo, Titilayo Gbajabiamila, Nicholas K. Irurhe, Samuel A. Fayemiwo, Shuwaram A. Shettima, Nkolika Stella Uwaezuoke, Chinagozi Precious Edwin, Toyese Stephen Ayanbeku, Joy U. Okaa, Charles John Elikwu, David W. Denning, Phyllis J. Kanki, Folasade T. Ogunsola
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background and objectives: Commercial Aspergillus IgG antibody assays have become pivotal in the current diagnosis of chronic pulmonary aspergillosis (CPA). However, diagnostic cutoffs have been found to vary from manufactures’ recommendations in d
Externí odkaz:
https://doaj.org/article/486b8552a0944c63b161f53d030c2e6a
Autor:
Rita O, Oladele, Akaninyene A, Otu, Oluwaseyi J, Balogun, Oladayo M, Babalola, Augustina O, Nwosu, Iriagbonse, Iyabo Osaigbovo, Titilayo, Gbajabiamila, Nicholas K, Irurhe, Samuel A, Fayemiwo, Shuwaram A, Shettima, Nkolika Stella, Uwaezuoke, Chinagozi Precious, Edwin, Toyese Stephen, Ayanbeku, Joy U, Okaa, Charles John, Elikwu, David W, Denning, Phyllis J, Kanki, Folasade T, Ogunsola
Publikováno v:
Therapeutic Advances in Infectious Disease
Background and objectives: Commercial Aspergillus IgG antibody assays have become pivotal in the current diagnosis of chronic pulmonary aspergillosis (CPA). However, diagnostic cutoffs have been found to vary from manufactures’ recommendations in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f0e43ff3624b6d59e542d7c5d63e77d
https://pubmed.ncbi.nlm.nih.gov/34646555
https://pubmed.ncbi.nlm.nih.gov/34646555